These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 315629)

  • 21. Characterization of the specificity of DR monoclonal antibodies.
    Molinaro GA; Quaranta V; Ferrone S
    Transplant Proc; 1979 Dec; 11(4):1748-50. PubMed ID: 93799
    [No Abstract]   [Full Text] [Related]  

  • 22. T cell regulation of specific B cell responses.
    Campos-Neto A; Levine H; Schlossman ST
    J Immunol; 1978 Dec; 121(6):2235-40. PubMed ID: 309894
    [No Abstract]   [Full Text] [Related]  

  • 23. Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive, I-A-restricted T cell clones.
    Jones B; Tite JP; Janeway CA
    J Immunol; 1986 Jan; 136(1):348-56. PubMed ID: 2415625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes.
    Barnaba V; Franco A; Alberti A; Benvenuto R; Balsano F
    Nature; 1990 May; 345(6272):258-60. PubMed ID: 2110296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonal analysis of B and T cell responses to Ia antigens. III. Characterization of 12 xenogeneic anti-idiotypic antisera to A.TH-derived anti-I-Ak and anti-I-Ek monoclonal antibodies.
    Devaux C; Pierres M
    J Immunol; 1982 Feb; 128(2):751-7. PubMed ID: 6172506
    [No Abstract]   [Full Text] [Related]  

  • 26. Passive enhancement of mouse skin allografts. Specificity of the antiserum for major histocompatibility.
    Staines NA; Guy K; Davies DA
    Transplantation; 1974 Aug; 18(2):192-5. PubMed ID: 4602953
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of SJL T cell clones responsive to syngeneic lymphoma (RCS): RCS-specific clones are stimulated by activated B cells.
    DeKruyff RH; Brown PH; Thorbecke GJ; Ponzio NM
    J Immunol; 1985 Nov; 135(5):3581-6. PubMed ID: 2413126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T lymphocyte-mediated cytotoxicity against autologous EBV-genome-bearing B cells.
    Tsoukas CD; Fox RI; Slovin SF; Carson DA; Pellegrino M; Fong S; Pasquali JL; Ferrone S; Kung P; Vaughan JH
    J Immunol; 1981 May; 126(5):1742-6. PubMed ID: 6163816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B cell destruction by T cell-derived factors.
    Quintáns J; Dick RF
    J Immunol; 1983 Oct; 131(4):1609-10. PubMed ID: 6352800
    [No Abstract]   [Full Text] [Related]  

  • 30. Generation and characterization of a clonotypic antibody specific for the T cell receptor of an arthritogenic T cell clone--studies in adjuvant arthritis.
    van Tienhoven EA; Steenbakkers PG; Veenstra JG; van Kooten PJ; van der Cammen MJ; Broeren CP; van Eden W
    J Autoimmun; 2000 Aug; 15(1):1-8. PubMed ID: 10936022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A new B-cell alloantigen of the rat].
    Fujimoto Y
    Hokkaido Igaku Zasshi; 1984 Jul; 59(4):412-24. PubMed ID: 6237970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of human T lymphocyte clones highly cytotoxic for an EBV-transformed B cell line in serum-free medium: isolation of clones that differ in phenotype and specificity.
    Spits H; Ijssel H; Terhorst C; de Vries JE
    J Immunol; 1982 Jan; 128(1):95-9. PubMed ID: 6274958
    [No Abstract]   [Full Text] [Related]  

  • 33. Lymphocyte subsets and surface molecules in man.
    Krensky AM; Lanier LL; Engleman EG
    Clin Immunol Rev; 1985; 4(1):95-138. PubMed ID: 2992859
    [No Abstract]   [Full Text] [Related]  

  • 34. Characterization of monoclonal antibodies that define rat T cell alloantigens.
    Ely JM; Greiner DL; Lubaroff DM; Fitch FW
    J Immunol; 1983 Jun; 130(6):2798-803. PubMed ID: 6343484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal analysis of B and T cell responses to Ia antigens. IV. Proliferative T cell clones recognizing E beta and/or E alpha allodeterminants.
    Pierres A; Pierres M
    J Immunol; 1983 Mar; 130(3):1262-7. PubMed ID: 6185575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective suppression of humoral and cell-mediated immune responses to rat alloantigens by monoclonal antibodies produced by hybridoma cell lines.
    McKearn TJ; Weiss A; Stuart FP; Fitch FW
    Transplant Proc; 1979 Mar; 11(1):932-5. PubMed ID: 377725
    [No Abstract]   [Full Text] [Related]  

  • 37. Evidence for a cloned hybridoma (HO-13-4-9) producing 2 kinds of antibody molecules different in specificity, one directed to Thy 1.2 gene products and the other to antigen on a subpopulation of Thy 1.1 thymocytes.
    Kubota E; Ishikawa H; Saito K
    J Immunol; 1981 Oct; 127(4):1498-503. PubMed ID: 6974196
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of cytolytic T lymphocyte clones reactive with Moloney leukemia virus-associated antigens by monoclonal antibodies: a direct approach to the study of H-2 restriction.
    Weiss A; MacDonald HR; Cerottini JC; Brunner KT
    J Immunol; 1981 Feb; 126(2):482-5. PubMed ID: 6450244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diversity of T cells recognizing transplantation antigens: mechanism of antigen recognition.
    Wekerle H; Lanai P; Feldman M
    Transplant Proc; 1973 Mar; 5(1):133-6. PubMed ID: 4144457
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of the major histocompatibility complex in T cell activation of B cell subpopulations: antigen-specific and H-2-restricted monoclonal TH cells activate Lyb-5+ B cells through an antigen-nonspecific and H-2-unrestricted effector pathway.
    Hodes RJ; Shigeta M; Hathcock KS; Fathman CG; Singer A
    J Immunol; 1982 Jul; 129(1):267-71. PubMed ID: 6177752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.